352 related articles for article (PubMed ID: 33323975)
41. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
[TBL] [Abstract][Full Text] [Related]
42. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
43. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
[TBL] [Abstract][Full Text] [Related]
44. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis.
Wang Q; Cheng ST; Chen J
Int J Med Sci; 2020; 17(12):1783-1794. PubMed ID: 32714081
[No Abstract] [Full Text] [Related]
45. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
46. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases.
Jin YM; Yun C; Park C; Wang HJ; Cho H
J Viral Hepat; 2001 Sep; 8(5):322-30. PubMed ID: 11555189
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.
Bak Y; Shin HJ; Bak Is; Yoon DY; Yu DY
Biochem Biophys Res Commun; 2015 Oct; 466(4):676-81. PubMed ID: 26392315
[TBL] [Abstract][Full Text] [Related]
48. HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes.
Zhao J; Wang W; Huang Y; Wu J; Chen M; Cui P; Zhang W; Zhang Y
DNA Cell Biol; 2014 Oct; 33(10):715-22. PubMed ID: 25050974
[TBL] [Abstract][Full Text] [Related]
49. Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.
Takeuchi Y; Tsuge M; Tsushima K; Suehiro Y; Fujino H; Ono A; Yamauchi M; Makokha GN; Nakahara T; Murakami E; Abe-Chayama H; Kawaoka T; Miki D; Imamura M; Aikata H; Hayes CN; Tateno C; Chayama K
J Infect Dis; 2020 Nov; 222(12):2061-2070. PubMed ID: 32514521
[TBL] [Abstract][Full Text] [Related]
50. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Zhang C; Liu P; Zhang C
J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
[TBL] [Abstract][Full Text] [Related]
52. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
53. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract][Full Text] [Related]
54. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation.
Hayashi M; Deng L; Chen M; Gan X; Shinozaki K; Shoji I; Hotta H
Microbiol Immunol; 2016 Jan; 60(1):17-25. PubMed ID: 26616333
[TBL] [Abstract][Full Text] [Related]
55. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
56. The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype.
Schollmeier A; Basic M; Glitscher M; Hildt E
J Virol; 2024 May; 98(5):e0042424. PubMed ID: 38629837
[TBL] [Abstract][Full Text] [Related]
57. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
58. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
Guerrieri F; Belloni L; Pediconi N; Levrero M
Semin Liver Dis; 2013 May; 33(2):147-56. PubMed ID: 23749671
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review.
Sivasudhan E; Blake N; Lu Z; Meng J; Rong R
Cells; 2022 Feb; 11(4):. PubMed ID: 35203390
[TBL] [Abstract][Full Text] [Related]
60. Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56γ-mediated dephosphorylation of protein kinase B.
Che L; Du ZB; Wang WH; Wu JS; Han T; Chen YY; Han PY; Lei Z; Chen XX; He Y; Xu L; Lin X; Lin ZN; Lin YC
Cell Prolif; 2022 Nov; 55(11):e13304. PubMed ID: 35811356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
